LDS/Medical Tests/Biopsy, Different Sites

Biopsy, Different Sites

In certain clinical scenarios, obtaining biopsies from multiple sites is practically and logistically feasible and clinically indicated. In pediatric populations, uncooperative and in patients with cognitive impairment, the biopsy procedures are best performed in an operating room under general anesthesia. If such patients require additional invasive procedures, they can be performed in the same sitting. This is common in the clinical management of pediatric malignancies such as neuroblastoma, rhabdomyosarcoma, melanoma; carcinoma of breast and lung; lymphomas, and systemic diseases such as sarcoidosis and amyloidosis, etc. Elderly people, patients with a strong family of cancers and individuals with germline mutations in protooncogenes and tumor suppressor genes are at a higher risk of developing neoplasms in different sites. Surveillance and screening programs in these individuals should include obtaining biopsies from different sites periodically. Preparing patients for different biopsies often involves a multidisciplinary teams and careful planning of the procedures. Some procedures may even require intraoperative assessment for adequacy. Risks and complications of such procedures vary from case to case.

  • Staging malignant neoplasms; carcinoma, melanoma, lymphoma and pediatric neoplasms
  • Surveillance of premalignant conditions such as Barret esophagus, colonic polyps, prostatic hyperplasia, cervical intraepithelial neoplasms, etc.
  • Management of systemic inflammatory conditions such as sarcoidosis and amyloidosis
  • Diagnosis of infectious processes
Interpretation of the biopsies from different sites is dependent on the clinical presentation and pathologic findings.

There are no universal reference ranges and the findings depend on the site biopsy taken.

Cytology specimens are used to prepare direct smears, cytospin preparations and cell blocks. Smears are stained with Pap stain and/or Geimsa stains. Biopsies are stained with hematoxylin and eosin, and various immunohistochemical stains at the discretion of the pathologist. If the sampling is adequate and a hematolymphoid neoplasm is clinically suspected, a fresh piece of tissue may be utilized for flow cytometric analysis.

Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory. Specimens requiring flow cytometry should be sent fresh to the laboratory in a sterile container or RPMI medium. Rarely, if culture is indicated, tissue for culture should be sent in a sterile container (or appropriate transport media) to the laboratory for microbiological assessment.

Varies from case to case.
Usually 24 hours for routine light microscopy, longer for immunohistochemical stains, flow cytometry and other ancillary studies which vary from case to case.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login